Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 2442 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 2832 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 3489 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 3682 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 3990 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 4017 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 4329 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 5088 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 5362 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 5371 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 5530 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 5567 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 5954 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 6078 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 6216 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 6359 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 6404 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 6585 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 6874 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 7049 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 7116 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 7164 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 7437 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 7484 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 7697 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 7705 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 7740 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 7757 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 7879 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 8479 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 8539 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 8661 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 8763 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 8787 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 8851 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 8897 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 8953 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 9068 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 9245 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 9879 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 10048 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 10081 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 10416 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 10851 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 10979 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 11096 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 11293 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 11525 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 11677 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 11902 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 11974 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 12018 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 12379 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 12406 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 12582 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 12888 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 12916 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 13315 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 13476 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 13589 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 13632 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 13736 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 14189 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 14407 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 14505 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 14564 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 14571 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 14963 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 15042 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 15150 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 15163 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 15551 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 15564 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 15601 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 15845 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 15854 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 16294 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 16469 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 16691 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 16893 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 17238 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 17750 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 17757 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 17788 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 17820 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18059 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18088 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18301 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18330 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18429 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18554 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18684 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18731 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18745 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18843 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18845 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18902 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18942 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 18957 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19016 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19054 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19144 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19192 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19194 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19209 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19213 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19217 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19234 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19259 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19316 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19332 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19378 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19388 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19433 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19544 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19580 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19820 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 19880 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 20228 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 20339 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 20352 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 20420 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 20486 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 20500 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 20554 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 20662 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 20937 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21082 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21092 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21150 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21310 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21504 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21507 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21551 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21560 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21578 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21612 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21759 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 21791 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 22243 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 22388 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 22500 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 22518 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 22527 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 22701 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 22935 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 23078 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 23285 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 23518 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 23698 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 23702 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 24098 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 24099 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 24279 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 24311 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 24435 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 24478 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 25044 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 25111 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 25231 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 25249 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 25886 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 26000 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 26539 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 26680 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 26787 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 26871 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 26975 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 27162 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 27420 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 27524 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 27777 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 27832 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 27873 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 27929 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 28530 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 29021 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 29075 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 29833 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 29957 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 30145 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 30654 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 30992 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 31772 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 32319 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 32536 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 34479 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 34664 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 34739 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 34774 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 34873 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 35422 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 35543 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 36368 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 37160 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 38235 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 40400 | Peak area normalized | No | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 41064 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 41650 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLUTAMINE (M-H)- | 45081 | Peak area normalized | Yes | PAH | Female | Cath |
Return to search page